Identity
- Security key
- 19327
- Ticker
- NSRX
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2025-08-13
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- NSRX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $37,924,280.63
- Shares outstanding (class)
- 11,710,808
- Shares outstanding (weighted)
- 11,710,808
- SIC
- —
- Employees
- 7
- Location
- —
- Homepage
- https://www.nasuspharma.com
- Description
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Market cap and share counts drift.